Sounds about right. When management say they have a better product than MSB for AGVHD for a larger market and point out the difference in valuation then its worth taking note of. MSB post ph3 rejection at their lowest MC was around 200 to 300 million. That's still 5x from our current MC.
- Forums
- ASX - By Stock
- CYP Price Target post MSB FDA approval.
CYP
cynata therapeutics limited
Add to My Watchlist
2.94%
!
16.5¢

Sounds about right. When management say they have a better...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $37.28M |
Open | High | Low | Value | Volume |
16.5¢ | 16.5¢ | 16.5¢ | $10.84K | 65.74K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 422794 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 34478 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 422794 | 0.165 |
7 | 1307381 | 0.160 |
2 | 16451 | 0.155 |
3 | 115000 | 0.150 |
4 | 98937 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 34478 | 2 |
0.175 | 35558 | 1 |
0.180 | 113494 | 5 |
0.185 | 38745 | 2 |
0.190 | 199688 | 4 |
Last trade - 10.52am 16/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |